This inventor holds 1 USPTO granted patent. Top assignee: Advinus Therapeutics Private Limited. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Innovations of Dilip Jadhav in Medicinal Chemistry
Introduction
Dilip Jadhav is a notable inventor based in Pune, India, recognized for his contributions to medicinal chemistry. He has developed innovative compounds that have significant implications for treating various diseases. His work focuses on the creation of substituted fused tricyclic compounds, which are essential in the pharmaceutical industry.
Latest Patents
Dilip Jadhav holds a patent for "Substituted fused tricyclic compounds, compositions, and medicinal applications thereof." This invention relates to a specific formula of compounds that can be utilized in treating conditions mediated by JAK activity. The patent outlines the potential of these compounds in addressing a wide range of diseases, including arthritis, Alzheimer's disease, cancer, and autoimmune disorders. The compounds are designed to provide therapeutic benefits in the treatment, prevention, or suppression of these conditions.
Career Highlights
Dilip Jadhav is currently associated with Advinus Therapeutics Private Limited, where he continues to innovate in the field of medicinal chemistry. His work has contributed to advancements in pharmaceutical formulations and therapeutic applications. His expertise in developing compounds that target JAK activity has positioned him as a valuable asset in the research and development sector.
Collaborations
Throughout his career, Dilip has collaborated with esteemed colleagues such as Dinesh Barawkar and Anish Bandyopadhyay. These collaborations have fostered
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile